Angiotensin is an important regulator of blood pressure and exerts both pressor actions and influences growth in the cardiovascular system via the AT 1 receptor. This
Introduction: angiotensin and the vasculature
Ever since its discovery over 50 years ago the octapeptide angiotensin (AII) has excited intense interest as a regulator of blood pressure, sodium and water balance. Although AII was originally described as a pressor agent, it is now also viewed as a growth factor for vascular smooth muscle. 1 Currently four putative subtypes of receptor for AII have been described AT 1 , AT 2 , AT 3 and AT 4 (reviewed in reference 2); two of these, the AT 1 and the AT 2 receptor have been cloned. Most of the vascular actions of AII are mediated by AT 1 receptors, 3 and consequently this review will focus on signalling mechanisms linked to this receptor subtype. Cloning and sequencing studies have indicated that the AT 1 receptor is a member of the seven transmembrane domain G protein coupled receptor superfamily (R 7 G). This superfamily of receptors typically effect signal transduction by coupling to a heterotrimeric G protein. The receptor-G protein complex acts as the initial event conveying information across the membrane from the external environment of the cell to its interior. 4 In recent years AII has been shown to activate multiple signalling systems in vascular smooth muscle (reviewed in references 5-7). Increasingly the pattern of signals activated by R 7 G receptors such as the AT 1 receptors can be seen to overlap considerably with other signalling systems eg, those activated by growth factors, 8 extracellular matrix, 9 or cytokines. 10 Despite this, responses to different stimuli in a particular cell type do differ substantially, as do responses to the same stimulus in different cell types. Any review (this one included) inevitably tends to obscure differences between cell types and present a rather generalised scheme of signalling which may apply to no cell in particular. This may Correspondence: AD Hughes review describes a number of signalling mechanisms involved in vasoconstriction and growth in response to AT 1 receptor activation in vascular smooth muscle.
be a particular risk when results from cultured smooth muscle cells which dedifferentiate into a synthetic phenotype are combined with data obtained in freshly isolated smooth muscle cells or intact blood vessels. With these caveats this review arbitrarily separates signalling pathways proposed to be involved in the vasoconstriction seen in contractile cells and growth induced by AII in cultured smooth muscle cells. Such a division is artificial but it may help clarify the increasingly confusing picture of AII signalling in vascular smooth muscle. ] i is the primary signal initiating force production in smooth muscle. 11 An increase in [Ca 2+ ] i activates calmodulin (CaM) which in turn activates myosin light chain kinase (MLCK). Phosphorylation of the myosin regulatory light chain (MLC 20 ) by MLCK allows the actin-myosin interaction to proceed with resultant ATP hydrolysis, crossbridge formation and force generation. 12 The sensitivity of the contractile process to [Ca 2+ ] i can also be influenced by contractile agonists, probably through modulation of myosin phosphatase activity 13 or by mitogen activated kinase (MAP kinase) dependent phosphorylation of thin filament proteins caldesmon and calponin, 14 and there is evidence that AII can enhance ␣ 1 -adrenoceptor mediated contraction in rabbit aorta by activation of protein kinase C (PKC). 15, 16 Surprisingly AII has also been reported to induce a reduction in response to potassium in rabbit mesenteric arteries by a mechanism dependent on a transcriptional process. 17 Although a rise in [Ca 2+ ] i appears almost obligatory for contraction, there is evidence to indicate that the source of the elevated [Ca 2+ ] i in response to agonists differs between different vessels. In general, influx through calcium channels plays a more major role than release from intracellular stores in the smaller arteries which maintain peripheral resistance 18, 19 and responses to AII in small human resistance arteries (ෂ200-300 m internal diameter) are completely abolished by removal of extracellular Ca 2+ (Garcha & Hughes, unpublished data).
Angiotensin II-induced vasoconstrictor signals

Phospholipase C (PLC) and protein kinase C (PKC)
PLC hydrolyses a minor membrane lipid component, phosphatidylinositol 1,4-bisphosphate (PIP 2 ) into IP 3 and 1,2-diacylglycerol (DAG). In isolated arteries, AII stimulation is associated with increased IP 3 20 and DAG 21 and both these products have signalling roles. The isoform of PLC linked to AT 1 receptors in vascular smooth muscle is uncertain. In many cell types (eg, hepatocytes) AT 1 receptors stimulate a PLC-␤ isoform acting through a specific heterotrimeric G protein (G q /G 11 ), 22 however some studies have failed to find PLC-␤ in vascular smooth muscle 23, 24 and a role for other isoforms cannot be excluded.
IP 3 generated by PLC is a diffusible cytoplasmic messenger which binds to an IP 3 receptor located in the endoplasmic reticulum. Binding of IP 3 results in the opening of a Ca 2+ permeable channel permitting sequestered Ca 2+ to be released into the cytoplasm. This mechanism accounts for the ability of many contractile agonists to release Ca 2+ from intracellular stores and it is assumed that it contributes to AIIinduced store release. However release of Ca 2+ from intracellular stores does not necessarily arise via generation of IP 3 . In portal vein myocytes AII caused release of intracellular Ca 2+ from stores sensitive to caffeine and ryanodine, 25 but release was unaffected by intracellular heparin or anti PdtIns antibody, inhibitors of IP 3 and IP 3 generation respectively. Since release of stores was inhibited by a dihydropyridine antagonist of L-type calcium channels it was proposed that AII-induced entry of Ca 2+ via L-type channels caused Ca 2+ -induced Ca 2+ release from intracellular stores in these cells. 26 Unlike IP 3 , DAG is retained in the plasmalemma where it binds to protein kinase C inducing it to relocate from the cytoplasm to the cell membrane and become active. Activated PKC phosphorylates a variety of substrates including calcium channels 27 and regulatory components of the contractile machinery.
14 However the importance of PKC to contraction is still disputed. Early studies with poorly selective inhibitors may well have overemphasised the importance of PKC in agonistmediated responses, 28 and more recent studies using more selective inhibitors or down regulation by exposure to phorbol esters have indicated a smaller role for classical isoforms of PKC in agonist-induced contraction. 15, 16, 29 DAG is also a precursor of arachidonic acid and AII stimulates PLA 2 activity in rat vascular smooth muscle cells. 30 Inhibition of lipoxygenase has been reported to attenuate AII-induced vasoconstriction in rat aorta. 31 
Tyrosine kinases
The role of tyrosine kinases in the action of AII will be discussed in more detail in the context of AIIinduced growth, however there is increasing evidence that tyrosine phosphorylation of cellular proteins is involved in the contractile action of many contractile agonists, including AII in vascular smooth muscle (reviewed by Hollenberg 32 ). Tyrosine phosphorylation could be involved in regulating a number of important elements in excitation-contraction coupling process including K channels 33 and L-type calcium channels, [34] [35] [36] as well as the contractile machinery. 37, 38 In rat aorta, 39 rat mesenteric 40 and gracilis resistance arteries 39 and porcine coronary artery. 41 AII-induced contraction was inhibited by selective antagonists of tyrosine kinases and exposure to AII was also associated with tyrosine phosphorylation of several proteins in rat aorta in vivo. 
Ion channel modulation by AII
AII induces depolarisation of blood vessels 42 and there is considerable evidence that modulation of ion channel opening is an important mechanism by which angiotensin induces vasoconstriction. Several ion channels have been reported to be affected by AII in vascular smooth muscle.
Voltage operated calcium channels (L-type channels):
The majority of agonist-induced Ca 2+ influx into smooth muscle cells probably occurs through L-type calcium channels (VOC). 43 AII has been shown to increase voltage-gated calcium channel currents in single arterial smooth muscle cells isolated from guinea pig mesentery 44 and rat portal vein. 45 In both cell types this effect was mediated by a heterotrimeric G protein and in portal vein cells the isoform was identified as G ␣13 . In rat portal vein the action of AII was blocked by inhibition of PKC and mimicked by phorbol esters, but not blocked by PtdIns antibody, implying involvement of PKC, but not PLC in this response. In view of the recent observations that AII can activate pp60src in vascular smooth muscle cells 46 and that pp60src can increase calcium channel currents, 47 it is possible that activation of pp60src also participates in the ability of AII to increase VOC. ] i directly, and inducing membrane depolarisation and opening of L-type channels as a result of the increased Na + permeability. Recent whole cell and single channel data suggests that this cation channel may be directly activated by G proteins 51 (and Hughes and Wijetunge, unpublished data).
K channels: K channels are a major determinant of membrane potential in vascular smooth muscle cells. 52 Three major classes of K channels are commonly found in vascular smooth muscle cells, delayed rectifier channels (K V ), Ca 2+ -activated K channels (BK Ca ) and ATP-dependent K channels K ATP . There is evidence that AII can modulate each of these channel types.
AII was reported to inhibit K V channels in freshly isolated rabbit portal vein cells 33 by a mechanism involving PKC. Similarly the ability of AII to inhibit opening of K ATP channels in rat mesenteric arterial cells was blocked by inhibitors of PKC or downregulation of PKC by exposure to phorbol esters. 53 The isoform of PKC mediating the effect of AII on K ATP channels was not defined in these studies, but since [Ca 2+ ] i was buffered to low levels it is unlikely that a classical Ca 2+ dependent isoform of PKC was responsible. In contrast the inhibitory action of AII on K ATP channels in cultured porcine coronary artery cells 54 and block of BK Ca channel opening in porcine coronary artery cells was reported not to involve PKC. 55 Chloride channels: The possible role of increases in chloride conductance as a depolarising mechanism involved in excitation-contraction coupling in vascular smooth muscle is attracting increasing interest. Ca 2+ -activated Cl − channels have been described in vascular smooth muscle 56 and are activated in response to release of Ca 2+ from intracellular stores. AII has been reported to induce Cl − channel opening in vascular smooth muscle cells 57 and inhibitors of Cl − channels inhibit renal arteriolar contraction induced by AII. 58, 59 Angiotensin II as a growth factor in the vasculature Changes in vascular structure can take several forms; growth involving an increase in cell number (hyperplasia) or an increase in cell size (hypertrophy) and a change in vascular structure in the absence of net change in muscle mass (eutrophic remodelling) have all been described. Growth and/or remodelling of blood vessels occurs in a number of physiological and pathological situations and it is often difficult to determine whether vasoconstrictors such as AII alter wall structure as a result of changes in intravascular pressure, vascular wall stress, haemodynamics, alteration of sympathetic nerve activity, 60 or through a direct growth factor-like action. In vivo AII has been shown to induce smooth muscle proliferation measured by incorporation of bromodeoxyuridine in the balloon injured rat carotid artery. 61 In a later study using the same model the effect of AII was shown to be more marked on neointimal cells and that medial proliferation in response to AII was transient in uninjured regions of the vessel compared with the sustained mitogenic action of AII on the neointima. 62 The growth promoting effect of AII on neointimal cells has been reported to be independent of sympathetic activation. 63 In contrast, AII was reported to only increase protein, but not DNA, synthesis in isolated rat aorta studied using an organ culture technique. 64 This may imply that AII requires other cofactors for expression of its mitogenic potential within the intact blood vessel.
There are conflicting reports regarding the effect of AII on cultured smooth muscle. In some studies of rat aortic smooth muscle cells AII acts primarily as a hypertrophic agent, stimulating protein synthesis 65, 66 though increased DNA synthesis and proliferation have been reported. 67 Similarly, a number of studies have reported that AII increases cell number 68, 69 or thymidine incorporation 70 by cultured human aortic smooth muscle cells. In contrast cultured human saphenous vein cells did not proliferate in response to AII 71 ] i and c-fos expression in these cells. While these differences may reflect differences in receptor number or coupling between cell types, it has also been proposed they may relate to AII-induced production of autocrine/paracrine growth factors such as TGF-␤, bFGF and PDGF-AA.
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Signals involved in AII-induced growth in the vasculature
Phospholipase C (PLC)
While PLC-␤ is generally considered to be involved in mediating responses to AII in cultured vascular smooth muscle cells, 75 recent data has also implicated PLC-␥ in mediating AII-induced PIP 2 hydrolysis in cultured smooth muscle cells. 76 However a major role of PLC-␥ seems inconsistent with reports that tyrosine kinase inhibitors which would be anticipated to inhibit activation of PLC-␥ fail to inhibit the rise in IP 3 ] i and consequent activation of calmodulin to subsequent responses, eg, proliferation and protein synthesis is uncertain.
In addition to PLC, another phospholipase (PLD) may also play a role in activation of PKC by AII in vascular smooth muscle cells. 80 Activation of PLD is not associated with a rise in IP 3 but has been reported to be the major source of DAG in cultured rat aortic smooth muscle cells. 81 Activation of PLD is partially dependent on the rise in [Ca 2+ ] i 82 and may also involve activation of tyrosine kinases. 83 DAG produced by PLC or PLD stimulates PKC. Activation of PKC by AII has been reported to be required for AII-induced growth in several studies of cultured vascular smooth muscle cells. [84] [85] [86] [87] Tyrosine phosphorylation: The potential role of tyrosine phosphorylation in AII-induced growth in cultured smooth muscle cells has attracted considerable interest recently (reviewed in reference 88). AII induces tyrosine phosphorylation of multiple proteins in cultured rat aortic vascular smooth muscle cells. 89, 90 A lesser and more transient degree of tyrosine phosphorylation was seen in human aortic smooth muscle cells. 71 Focal adhesion kinase (p125FAK), 91 paxillin, 92,91 pp60src 93 and MAP kinases 71 (also known as ERK1 and ERK2) have all been identified as important targets in rat smooth muscle cells. Several studies have demonstrated that inhibition of tyrosine kinases blocks protein synthesis, 66 or DNA synthesis 94 in response to AII. The precise mechanism by which AII causes tyrosine phosphorylation is poorly understood as the AT 1 receptor lacks intrinsic tyrosine kinase activity. It has been proposed that the ␤␥ subunit of heterotrimeric G proteins may stimulate cytoplasmic tyrosine kinase such as pp60src, 95 but it is possible that G protein-mediated activation of phosphatidylinositol 3-kinase as described by Saward and Zahradka 96 might also contribute to this action. Activation of pp60src appears to play a key role in tyrosine phosphorylation-dependent activation of signals in smooth muscle. Inhibition of pp60src by anti-src antibodies inhibits AII-induced activation of PLC-␥, p21 ras and prevents proliferation in permeabilised rat aortic smooth muscle cells. 93 There is also evidence that a Ca 2+ -dependent tyrosine kinase may contribute to AII-induced tyrosine phosphorylation, possibly in conjunction with PKC, 89 since tyrosine phosphorylation of several proteins 97 including paxillin can be blocked by preventing the rise in [Ca 2+ ] i following AII. It has been suggested that this Ca 2+ -dependent tyrosine kinase could be related to another Ca
2+
-dependent tyrosine kinase, PYK2, previously described in neuronal cells. 98 Another class of tyrosine kinases linked to AT 1 receptor activation is the Janus kinase (JAK) family. The JAK/STAT pathway is a signalling pathway comprising a number of tyrosine kinases and transcription factors. This pathway was originally identified as a mediator of the action of a number of cytokines. Stimulation of AT 1 receptors has recently been shown to induce activation of JAK2 and to a lesser extent TYK2 in rat aortic smooth muscle cells and in the same studies the AT 1 receptor was shown to co-immunoprecipitate with JAK2, but not with JAK1 or TYK2. 99 
Conclusions
Recent years have seen a considerable increase in the number and complexity of signalling pathways linked to AT 1 receptor activation in vascular smooth muscle. Increasingly it has become difficult to differentiate pathways activated by R 7 G receptors from those activated by growth factors, cytokines or extracellular matrix molecules. However different cells and tissues do not necessarily express all of these systems or respond to AII in similar manners. Determining how cells regulate the pattern of intracellular signals evoked by AII and other agonists in the vasculature is an important goal in directing research into novel therapeutic strategies and understanding disease processes in the vasculature.
